Ribobay established in August 2021, is a wholly-owned subsidiary of General Biol. The company is located in Quanjiao industry Zone in Chuzhou, part of the Nanjing metropolitan area. Ribobay focuses on the field of medicinal oligonucleotides CXO, which is one of the important layouts for General Biol's CXO business expansion.
- 22 2022-07
General Bioll installation Cytiva China's first ÄKTA oligosynt
On July 7, 2022, General Biol (Anhui) Co., Ltd. installed Cytiva's first ÄKTA oligosynt equipment in China, completed the equipment installation and operation verification, and has been put into use.
- 25 2022-02
General Biol cooperates with Cytiva to build the world's first kg-level oligonucleotides production FlexFactory(TM) flexible factory project
General Biol cooperates with Cytiva to build the world's first oligonucleotides flexible factory (Oligo FlexFactory). With the investment of hundreds of millions of CNY, the production facility is expected to achieve an annual production capacity of hundreds of kilograms of GMP-grade oligonucleotides after completion.